American Oriental Bioengineering (AOBO) is firmly planted in the pharmaceutical industry. Through subsidiaries, AOBO makes more than 90 plant-based pharmaceuticals and nutraceuticals based on Traditional Chinese Medicine (TCM). Its products (primarily sold in China) include prescription and over-the-counter herbal and vitamin beverages, pills, gels, patches, and powders to treat a variety of ailments from bedwetting to respiratory diseases. It sells directly to retail stores, pharmacies, hospitals, and independent distributors who act as resellers. AOBO, which was founded in 1970, operates about 30 offices throughout China. CEO Tony Liu has a controlling ownership stake (about 40%) in the company.
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Get in Touch with 4 Principals*
Yanchun LiLegal Representative
Weiwei CaoLegal Representative
Kelisituofu Maikeer NasenLegal Representative